Baidu
map
PHYTOMEDICINE 润色咨询

PHYTOMEDICINE

出版年份:1994 年文章数:2603 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2024-05-25 ms9000000937692960 来自四川省

    审稿速度:1.0
    偏重的研究方向:中药单体;神经病学
    经验分享:3.11投稿
    3.15 under review
    4.15 revise
    5.15 返修回去
    目前在等下一步消息

    30

    展开30条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2020-02-18 1210fdb9m61(暂无昵称)

    请问下您的文章现在是什么状态啊5675545 2019-12-27 发表::
    under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思
    5675545 2019-12-27 00:00:00 发表:
    under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思

    5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2024-06-27 146d82c1m83暂无昵称 来自江苏省

    一个半月了,还在 under editor assessment,大家也是这么久么

    7

    展开7条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2024-05-26 ms8000001555903844 来自北京

    这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2024-06-26 ms9000000486868165 来自天津

    我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。

    7

    展开7条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2023-12-28 samtol 来自浙江省

    让我修了两轮的格式和图片
    12.25 submitted to journal
    12.26 under editor assessment

    39

    展开39条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2023-04-18 ms2000000770833142 来自广东省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:中药复方;代谢病
    经验分享:2023.02.25 submit
    2023.03.03 under editor assessment
    2023.03.09 under review
    2023.03.19 required reviews completed
    2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。
    2023.04.12 返回
    2023.04.17 under editor assessment
    2023.04.18 reviewer invited
    目前是这种状态,后续再更新状态。

    希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。
    编辑和杂志都不错,效率其实还行。

    希望能赶在毕业前接收~

    22

    展开22条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2024-05-29 ms6000000875594652 来自江西省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:植物提取物;生殖
    经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2022-05-10 ms3000000915988761

    偏重的研究方向:中药单体;药理;中药药理
    经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐

    13

    展开13条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0<br>偏重的研究方向:中药单体;神经病学<br>经验分享:3.11投稿<br>3.15 under review<br>4.15 revise<br>5.15 返修回去<br>目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=584917, encodeId=231b58491e6c, content=请问下您的文章现在是什么状态啊<span class="quote">5675545 2019-12-27 发表::<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span><span class="quote">5675545 2019-12-27 00:00:00 发表:<br>under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思</span>, beContent=5675545 2019-12-27 发表:: under review后变成了Under Editor Evaluation但这个状态持续了10天,中间时间还变了两次,这是啥意思, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06582225192, createdName=1210fdb9m61(暂无昵称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212001, encodeId=a26f221200186, content=一个半月了,还在 under editor assessment,大家也是这么久么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Thu Jun 27 21:42:15 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊,是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211666, encodeId=7db6221166655, content=我是4月19日投稿,4月22日,编辑说格式改一改,然后当天我们就改投出去,5月22送审,中间发邮件问了一次,6月3日看到有3个审稿人,其中有一个专家审稿结束,6月12日审稿延毕,6月16日早上6点老师给我发邮件说返修,非常感谢编辑和审稿人特别有耐心,给我返修的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee48101892, createdName=ms9000000486868165, createdTime=Wed Jun 26 06:25:55 CST 2024, time=2024-06-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物提取物;生殖<br>经验分享:请问大家有没有遇到这样的情况: 我已经送审一个多月了 发送了50个邀请 但是一直没有专家同意审稿,请问我该怎么办呢?会不会有拒稿的风险?可以不可以自己推荐审稿人?拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1218594, encodeId=20ba1218594c5, content=偏重的研究方向:中药单体;药理;中药药理<br>经验分享:求助各位大佬,我因为参考文献格式被send back N次了,到底应该是什么格式啊天呐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Tue May 10 22:33:41 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190337, encodeId=5e1e219033ef6, content=请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Fri Mar 01 10:33:42 CST 2024, time=2024-03-01, status=1, ipAttribution=江苏省)]
    2024-03-01 ms7000001623486299 来自江苏省

    请问这个期刊一般多久发正式proof,我看文章已经online了,但没有收到proof

    7

    展开7条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map